Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study

被引:62
作者
Bensen, Jeannette T. [1 ,2 ]
Tse, Chiu Kit [1 ]
Nyante, Sarah J. [3 ]
Barnholtz-Sloan, Jill S. [4 ]
Cole, Stephen R. [1 ]
Millikan, Robert C. [1 ,2 ]
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[4] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
关键词
MicroRNA; Breast cancer; Germline; Single nucleotide polymorphism; Risk; Survival; SINGLE-NUCLEOTIDE POLYMORPHISMS; BINDING-SITES; CELL-LINES; ENVIRONMENT INTERACTIONS; AFRICAN-AMERICAN; GENETIC-VARIANTS; MESSENGER-RNA; EXPRESSION; POPULATION; APOPTOSIS;
D O I
10.1007/s10552-013-0187-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Common germline variation in the 5' region proximal to precursor (pre-) miRNA gene sequences is evaluated for association with breast cancer risk and survival among African Americans and Caucasians. We genotyped nine single nucleotide polymorphisms (SNPs) within six miRNA gene regions previously associated with breast cancer, in 1,972 cases and 1,776 controls. In a race-stratified analysis using unconditional logistic regression, odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated to evaluate SNP association with breast cancer risk. Additionally, hazard ratios (HRs) for breast cancer-specific mortality were estimated. Two miR-185 SNPs provided suggestive evidence of an inverse association with breast cancer risk (rs2008591, OR = 0.72 (95 % CI = 0.53-0.98, p value = 0.04) and rs887205, OR = 0.71 (95 % CI = 0.52-0.96, p value = 0.03), respectively) among African Americans. Two SNPs, miR-34b/34c (rs4938723, HR = 0.57 (95 % CI = 0.37-0.89, p value = 0.01)) and miR-206 (rs6920648, HR = 0.77 (95 % CI = 0.61-0.97, p value = 0.02)), provided evidence of association with breast cancer survival. Further adjustment for stage resulted in more modest associations with survival (HR = 0.65 [95 % CI = 0.42-1.02, p value = 0.06] and HR = 0.79 [95 % CI = 0.62-1.00, p value = 0.05, respectively]). Our results suggest that germline variation in the 5' region proximal to pre-miRNA gene sequences may be associated with breast cancer risk among African Americans and breast cancer-specific survival generally; however, further validation is needed to confirm these findings.
引用
收藏
页码:1099 / 1109
页数:11
相关论文
共 63 条
  • [11] RNA polymerase III transcribes human microRNAs
    Borchert, Glen M.
    Lanier, William
    Davidson, Beverly L.
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (12) : 1097 - 1101
  • [12] Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer:: ITGB4 as prognostic marker
    Brendle, Annika
    Lei, Haixin
    Brandt, Andreas
    Johansson, Robert
    Enquist, Kerstin
    Henriksson, Roger
    Hemminki, Kari
    Lenner, Per
    Foersti, Asta
    [J]. CARCINOGENESIS, 2008, 29 (07) : 1394 - 1399
  • [13] microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
    Buffa, Francesca M.
    Camps, Carme
    Winchester, Laura
    Snell, Cameron E.
    Gee, Harriet E.
    Sheldon, Helen
    Taylor, Marian
    Harris, Adrian L.
    Ragoussis, Jiannis
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5635 - 5645
  • [14] Regulation of Myc by miR-34c A mechanism to prevent genomic instability?
    Cannell, Ian G.
    Bushell, Martin
    [J]. CELL CYCLE, 2010, 9 (14) : 2726 - 2730
  • [15] Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
    Chang, Tsung-Cheng
    Wentzel, Erik A.
    Kent, Oliver A.
    Ramachandran, Kalyani
    Mullendore, Michael
    Lee, Kwang Hyuck
    Feldmann, Georg
    Yamakuchi, Munekazu
    Ferlito, Marcella
    Lowenstein, Charles J.
    Arking, Dan E.
    Beer, Michael A.
    Maitra, Anirban
    Mendell, Joshua T.
    [J]. MOLECULAR CELL, 2007, 26 (05) : 745 - 752
  • [16] Intracellular and Extracellular MicroRNAs in Breast Cancer
    Corcoran, Claire
    Friel, Anne M.
    Duffy, Michael J.
    Crown, John
    O'Driscoll, Lorraine
    [J]. CLINICAL CHEMISTRY, 2011, 57 (01) : 18 - 32
  • [17] MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth
    Corney, David C.
    Flesken-Nikitin, Andrea
    Godwin, Andrew K.
    Wang, Wei
    Nikitin, Alexander Yu.
    [J]. CANCER RESEARCH, 2007, 67 (18) : 8433 - 8438
  • [18] Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes
    Duan, Shiwei
    Mi, Shuangli
    Zhang, Wei
    Dolan, M. Eileen
    [J]. RNA BIOLOGY, 2009, 6 (04) : 412 - 425
  • [19] Atypical transcription of microRNA gene fragments
    Gao, Jin Song
    Zhang, Yingjie
    Li, Ming
    Tucker, Lynne D.
    Machan, Jason T.
    Quesenberry, Peter
    Rigoutsos, Isidore
    Ramratnam, Bharat
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 (09) : 2775 - 2787
  • [20] The Met oncogene and basal-like breast cancer: another culprit to watch out for?
    Gastaldi, Stefania
    Comoglio, Paolo M.
    Trusolino, Livio
    [J]. BREAST CANCER RESEARCH, 2010, 12 (04):